Vaginal Misoprostol 1000 μg for early abortion

被引:24
作者
Carbonell, JLL [1 ]
Rodriguez, J
Aragón, S
Velazco, A
Tanda, R
Sánchez, C
Barambio, S
Chami, S
Valero, F
机构
[1] Clin Mediterrania Med, Valencia, Castello, Spain
[2] Hosp Docente Gineco Obstet Eusebio Hernandez, Havana, Cuba
[3] Clin Tutor Med, Barcelona, Spain
[4] Clin Isadora, Madrid, Spain
[5] Clin Delta Med, Murcia, Spain
关键词
Misoprostol; abortion;
D O I
10.1016/S0010-7824(01)00189-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The objective of this study was to evaluate the safety and efficacy of 1000 mug misoprostol vaginally (Cytotec) self-administered into the vagina for medical abortion. Three-hundred women with gestations between 42 and 63 days, with previous written consent, received vaginal misoprostol every 24 h up to a maximum of three doses for abortion. Outcome measures assessed included: successful abortion (complete abortion without surgery), side effects, decrease in hemoglobin. mean time of vaginal bleeding, mean expulsion time and mean time of returning of menses. Complete abortion occurred in 279/300 (93.0%. 95% CI 90, 96) patients. Medication to relieve symptoms was administered to all subjects after every misoprostol dose. Vaginal bleeding lasted 14.7 +/- 5.4 days. Mean expulsion time was 8.1 +/- 3.0 h for those who aborted after the first misoprostol dose. The mean drop in hemoglobin was statistically significant (p = 0.0001) but without clinical relevance. The frequencies of nausea and diarrhea were high. According to the observed outcomes, 1000-mug misoprostol vaginally could be a valid method to terminate pregnancies up to nine weeks gestation. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 23 条
[1]   THE BRAZILIAN EXPERIENCE WITH CYTOTEC [J].
BARBOSA, RM ;
ARILHA, M .
STUDIES IN FAMILY PLANNING, 1993, 24 (04) :236-240
[2]   Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion [J].
Bugalho, A ;
Faundes, A ;
Jamisse, L ;
Usfa, M ;
Maria, E ;
Bique, C .
CONTRACEPTION, 1996, 53 (04) :243-246
[3]  
BUGALHO A, 1994, OBSTET GYNECOL, V83, P729
[4]   PREGNANCY INTERRUPTION BY VAGINAL MISOPROSTOL [J].
BUGALHO, A ;
BIQUE, C ;
ALMEIDA, L ;
BERGSTROM, S .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1993, 36 (04) :226-229
[5]  
Carbonell J L, 1998, Eur J Contracept Reprod Health Care, V3, P93
[6]  
Carbonell J L, 2000, Eur J Contracept Reprod Health Care, V5, P46, DOI 10.1080/13625180008500367
[7]  
Carbonell J L, 1997, Eur J Contracept Reprod Health Care, V2, P181
[8]   Oral methotrexate and vaginal misoprostol for early abortion [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Cabezas, E ;
Fernández, C ;
Sánchez, C .
CONTRACEPTION, 1998, 57 (02) :83-88
[9]   The use of misoprostol for termination of early pregnancy [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Fernandez, C .
CONTRACEPTION, 1997, 55 (03) :165-168
[10]  
CARBONELL JLL, 1999, EUR J CONTRACEP REPR, V4, P1